Therapeutic and predictive targets of AKI

Clinical Nephrology

Volumn 70, Issue 6, 2008, Pages 453-463

  Yalavanthy, R ^a   Edelstein, Charles L ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Biomarkers; Fractalkine; Interleukin 18; Mesenchymal stem cells; NGAL

Indexed keywords

ABATACEPT; ACETYLGLUCOSAMINIDASE; ALPHA INTERMEDIN; ANTIINFLAMMATORY AGENT; CASPASE INHIBITOR; CHEMOKINE RECEPTOR CX3CR1 INHIBITOR; CLODRONIC ACID; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; ERYTHROPOIETIN; GELATINASE B; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 18 ANTIBODY; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6 ANTIBODY; KIDNEY INJURY MOLECULE 1; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD11B; MONOCYTE CHEMOTACTIC PROTEIN; MYCOPHENOLIC ACID; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; OPH 001; PROTECTIN D1; RANTES; RESOLVIN DERIVATIVE; UNCLASSIFIED DRUG;

ACUTE DISEASE; ANTIINFLAMMATORY ACTIVITY; CARDIOPULMONARY BYPASS; DISEASE MARKER; DISEASE SEVERITY; DRUG MEGADOSE; EARLY DIAGNOSIS; ENZYME ACTIVITY; HOSPITALIZATION; HUMAN; ISCHEMIA; KIDNEY INJURY; KIDNEY TRANSPLANTATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MORTALITY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN URINE LEVEL; REPERFUSION INJURY; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; UNSPECIFIED SIDE EFFECT;

EID: 57349151138     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp70453     Document Type: Review

References (83)

1. Abdelrahman M, Sharples EJ, McDonald MC et al. Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia. Shock. 2004; 22: 63-69.
2. Aggarwal A, Ong JP, Younossi ZM et al. Predictors of mortality and resource utilization in cirrhotic patients admitted to the medical ICU. Chest. 2001; 119: 1489-1497.
3. Bachorzewska-Gajewska H., Malyszko J, Sitniewska E et al. Neutrophil gelatinase-associated lipocalin (NGAL) correlations with cystatin C, serum creatinine and eGFR in patients with normal serum creatinine undergoing coronary angiography. Nephrol Dial Transplant. 2007; 22: 295-296.
4. Basile DP. The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function. Kidney Int. 2007; 72: 151-156.
5. Bates DW, Su L, Yu DT et al. Mortality and costs of acute renal failure associated with amphotericin B therapy. Clin Infect Dis. 2001; 32: 686-693.
6. Bellomo R, Kellum JA, Ronco C et al. Defining and classifying acute renal failure: from advocacy to consensus and validation of the RIFLE criteria. Intens Care Med. 2007; 33: 409-413.
7. Brodsky SV, Yamamoto T, Tada T et al. Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted endothelial cells. Am J Physiol Ren Physiol. 2002; 282: F1140-1149.
8. Burne MJ, Daniels F, El Ghandour A et al. Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure. J Clin Invest. 2001; 108: 1283-1290.
9. Chertow GM, Levy EM, Hammermeister KE et al. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med. 1998; 104: 343-348.
10. Day YJ, Huang L, Ye H, Linden J, Okusa MD. Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages. Am J Physiol Ren Physiol. 2005; 288: F722-F731.
11. De Greef KE, Ysebaert DK, Dauwe S et al. Anti-B7-1 blocks mononuclear cell adherence in vasa recta after ischemia. Kidney Int. 2001; 60: 1415-1427.
12. de Mendonca A, Vincent JL, Suter PM et al. Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score. Intens Care Med. 2000; 26: 915-921.
13. Deng J, Kohda Y, Chiao H et al. IL-10 inhibits ischemic and cisplatin-induced acute renal injury. Kidney Int. 2001; 60: 2118-2128.
14. Dennen P, Parikh CR. Biomarkers of acute kidney injury. Can we replace serum serum creatinine? Clin Nephrol 2007; 68: 269-278.
15. Duffield JS, Hong S, Vaidya VS et al. Resolvin D series and protectin D1 mitigate AKI. J Immunol. 2006; 177: 5902-5911.
16. Edelstein CL, Shi Y, Schrier RW et al. Role of caspases in hypoxia-induced necrosis of rat renal proximal tubules. J Am Soc Nephrol. 1999; 10: 1940-1949.
17. Edelstein CL, Yaqoob MM, Schrier RW et al. The role of the calcium-dependent enzymes nitric oxide synthase and calpain in hypoxia-induced proximal tubule injury. Ren Fail. 1996; 18: 501-511.
18. Edelstein CL, Wieder ED, Yaqoob MM et al. The role of cysteine proteases in hypoxia-induced rat renal proximal tubular injury. PNAS. 1995; 92: 7662-7666.
19. Faubel S, Ljubanovic D, Poole B et al. Peripheral CD4 T-cell depletion is not sufficient to prevent ischemic acute renal failure. Transplantation. 2005; 80: 643-649.
20. Fiorina P, Ansari MJ, Jurewicz M et al. Role of CXC chemokine receptor 3 pathway in renal ischemic injury. J Am Soc Nephrol. 2006; 17: 716-723.
21. Flores J, DiBona DR, Beck CH, Leaf A. The role of cell swelling in ischemic renal damage and the protective effect of hypertonic solute. J Clin Invest. 1972; 51: 118-126.
22. Friedwald JJ, Rabb H. Inflammatory cells in ischemic acute renal failure. Kidney Int. 2004; 66: 486-491.
23. Goldfarb M, Rosenberger C, Ahuva S et al. A role for erythropoietin in the attenuation of radiocontrast-induced acute renal failure in rats. Ren Fail. 2006; 28: 345-350.
24. Gong H, Wang W, Kwon TH et al. EPO and α-MSH prevent ischemia/ reperfusion-induced downregulation of AQPs and sodium transporters in rat kidney. Kidney Int. 2004; 66: 683-695.
25. Han WK, Bailly V, Abichandani R et al. Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. 2002; 62: 237-244.
26. Han WK, Waikar SS, Johnson A et al. Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int. 2007; 73: 863-869.
27. Horbelt M, Lee SY, Mang HE et al. Acute and chronic microvascular alterations in a mouse model of ischemic acute kidney injury. Am J Physiol Ren Physiol. 2007; 293: F688-F695.
28. Humphreys BD, Bonventre JV. Mesenchymal stem cells in acute kidney injury. Annu Rev Med. 2008; 59: 311-325.
29. Humphreys BD, Valerius MT, Kobayashi A et al. Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell. 2008; 2: 284-291.
30. Ichimura T, Bonventre JV, Bailly V et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is upregulated in renal cells after injury. J Biol Chem. 1998; 273: 4135-4142.
31. Ichimura T, Hung CC, Yang SA et al. Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am J Physiol Ren Physiol. 2004; 286: F552-F563.
32. Jo SK, Sung SA, Cho WY et al. Macrophages contribute to the initiation of ischernic acute renal failure in rats. Nephrol Dial Transplant. 2006; 21: 1231-1239.
33. Kale S, Karihaloo A, Clark PR, Kashgarian M, Krause DS, Cantley LG. Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. J Clin Invest. 2003; 112: 42-49.
34. Kashyap VS, Cambria RP, Davison JK et al. Renal failure after thoracoabdominal aortic surgery. J Vasc Surg. 1997; 26: 949-957.
35. Kelly KJ, Williams WW Jr, Colvin RB al. Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury. Proc Nat Acad Sci. 1994; 91: 812-816.
36. Kelly KJ, Williams WW Jr, Colvin PB et al. Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest. 1996; 97: 1056-1063.
37. Kolyada AY, Liangos O, Madias NE et al. Protective effect of erythropoietin against radiocontrast-induced renal tubular epithelial cell injury. Am J Nephrol. 2007; 28: 203-209.
38. Lameire N, Van Biesen W, Vanholder R. The changing epidemiology of acute renal failure. Nat Clin Pract Nephrol. 2006; 2: 364-377.
39. Lange C, Togel F, Ittrich H. Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats. Kidney Int. 2005; 68: 1613-1617.
40. Lee SH, Li C, Lim SW et al. Attenuation of interstitial inflammation and fibrosis by recombinant human erythropoietin in chronic cyclosporine nephropathy. Am J Nephrol. 2005; 25: 64-76.
41. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA. 1996; 275: 1489-1494.
42. Liangos O, Perianayagam MC, Vaidya VS et al. Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol. 2007; 18: 904-912.
43. Melnikov VY, Ecder T, Fantuzzi G et al. Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. J Clin Invest. 2001; 107: 1145-1152.
44. Melnikov VY, Faubel S, Siegmund B et al. Neutrophil-independent mechanisms of caspase-1-and IL-18-mediated ischemic acute tubular necrosis in mice. J Clin Invest. 2002; 110: 1083-1091.
45. Mishra J, Ma Q, Prada A et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol. 2003; 14: 2534-2543.
46. Mishra J, Mori K, Ma Q et al. Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol. 2004; 15: 3073-3082.
47. Mishra J, Dent C, Tarabishi R et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005; 365: 1231-1238.
48. Mishra J, Ma Q, Kelly C et al. Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatr Nephrol. 2006; 21: 856-863.
49. Mitra A, Bansal S, Wang W et al. Erythropoietin ameliorates renal dysfunction during endotoxaemia. Nephrol Dial Transplant. 2007; 22: 2349-2353.
50. Nagoya N, Fujii T, Iwase T et al. Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol. 2004; 287: H2670-2676.
51. Nickolas TL, O'Rourke MJ, Yang J et al. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med. 2008; 148: 810-819.
52. Obialo CI, Okonofua EC, Tayade AS, Riley LJ. Epidemiology of de novo acute renal failure in hospitalized African-Americans: comparing community-acquired vs. hospital-acquired disease. Arch Intern Med. 2000; 160: 1309-1313.
53. Oh DJ, Dursun B, He Z et al. Fractalkine receptor (CX3CR1) inhibition is protective against ischemic acute renal failure in mice. Am J Physiol Ren Physiol. 2008; 294: F264-271.
54. Parikh CR, McSweeney PA, Korular D et al. Renal dysfunction in allogeneic hematopoietic cell transplantation. Kidney Int. 2002; 62: 566-573.
55. Parikh CR, Jani A, Melnikov VY et al. Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis. 2004; 43: 405-414.
56. Parikh CR, Abraham E, Ancukiewicz M et al. Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol. 2005; 16: 3046-3052.
57. Parikh CR, Jani A, Mishra J et al. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant. 2006a; 6: 1639-1645.
58. Parikh CR, Mishra J, Thiessen-Philobrook H et al. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int. 2006b; 70: 199-203.
59. Rabb H, Mendiola CC, Dietz J et al. Role of CD11a and CD11b in ischemic acute renal failure in rats. Am J Physiol Ren Physiol. 1994; 267: F1052-171058.
60. Reyes M, Dudek A, Jahagirdar B et al. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest. 2002; 109: 337-346.
61. Segerer S, Alpers CE. Chemokines and chemokine receptors in renal pathology. Curr Opin Nephrol Hypertens. 2003; 12: 243-249.
62. Sharples EJ, Patel N, Brown P et al. Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J Am Soc Nephrol. 2004; 15: 2115-2124.
63. Shusterman N, Strom BL, Murray TG et al. Risk factors and outcome of hospital-acquired acute renal failure. Clinical epidemiologic study Am J Med. 1987; 83: 65-71.
64. Singbartl K, Green SA, Ley K. Blocking P-selectin protects from ischemia reperfusion-induced a cute renal failure. FASEB J. 2000; 14: 48-54.
65. Singbartl K, Ley K. Protection from ischemia reperfusion-induced severe acute renal failure by blocking E-selectin. Crit Care Med. 2000; 28: 2507-2514.
66. Singh AK, Szczech L, Tang KL et al. Correction of anemia with epoietin in chronic kidney disease. N Engl J Med. 2006; 355: 2085-2098.
67. Star RA. Treatment of acute renal failure. Kidney Int. 1998; 54: 1817-1831.
68. Sutton TA, Mang HE, Campos SA et al. Injury of the renal rmcrovascular endotheliurn alters barrier function after ischemia. Am J Physiol Ren Physiol. 2003; 285: F191-F198.
69. Trachtman H, Christen E, Cnaan A et al. Urinary neutrophil gelatinase-associated lipocalcin in D+HUS: a novel marker of renal injury. Pediatr Nephrol. 2006; 21: 989-994.
70. Uchino S, Kellum JA, Bellomo R et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005; 294: 813-818.
71. Vaidya VS, Ramirez V, Ichimura T et al. Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am J Physiol Ron Physiol. 2006; 290: F517-F529.
72. Van Biesen W, Vanholder R, Lameire N. Defining acute renal failure: RIFLE and beyond. Clin J Am Soc Nephrol. 2006; 1: 1314-1319.
73. van Timmeren MM, van den Heuvel MC, Bailly V et al. Tubular kidney injury molecule-1 (KIM-1) in human renal disease. J Pathol. 2007; 212: 209-217.
74. Vaziri ND, Zhou XJ, Liao SY. Erythropoietin enhances recovery from cisplatin-induced acute renal failure. Am J Physiol Ren Physiol. 1994; 266: F360-F366.
75. Vesey DA, Cheung C, Pat B et al. Erythropoietin protects against ischemic acute renal injury. Nephrol Dial Transplant. 2004; 19: 348-355.
76. Wagener G, Jan M, Kim M et al. Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology. 2006; 105: 485-491.
77. Washburn KK, Zappitelli M, Arikan AA et al. Urinary interleukin-18 is an acute kidney injury biomarker in critically ill children. Nephrol Dial Transplant. 2007; 23: 566-572.
78. Wu L, Tiwari MM, Messer KJ et al. Peritubular capillary dysfunction and renal tubular epithelial stress following lipopolysaccharide administration in mice. Am J Physiol Ren Physiol. 2007; 292: F261-268.
79. Yang CW, Li C, Jung JY et al. Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney. FASEB J. 2003; 17: 1754-1755.
80. Yasuda H, Yuen PS, Hu X et al. Simvastatin improves sepsis-induced mortality and AKI via renal vascular effects. Kidney Int. 2006; 69: 1532-1542.
81. Yokota N, O'Donnell M, Daniels F et al. Protective effect of HMG-CoA reductase inhibitor on experimental renal ischemia-reperfusion injury. Am J Nephrol. 2003; 23: 13-17.
82. Ysebaert DK, de Greef KE, Vercauteren SR et al. Effect of immunosuppression on damage, leukocyte infitration, and regeneration after severe warm ischemia/reperfusion renal injury. Kidney Int. 2003; 64: 864-873.
83. Zappitelli M, Washburn KK, Arikan AA et al. Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study. Crit Care. 2007; 11: R84.